Stem-Cell Aging and Pathways to Precancer Evolution

About this episode

Catriona Jamieson discusses the impact of stem cell aging and inflammation on the evolution of precancer and cancer, including insights from spaceflight research.

Pre-cancer and cancer can begin when stressed blood-forming stem cells lose their normal controls. Catriona Jamieson, M.D., Ph.D., UC San Diego, explains how inflammation-linked editing enzymes, repetitive elements in the genome, and stem cell stress shape the progression from myeloproliferative neoplasms to acute myeloid leukemia. Jamison examines how spaceflight accelerates stem cell aging, how some astronauts mobilize a resilient regenerative stem cell population, and how tumor organoids in space help reveal drug responses by activating the enzyme ADAR1. This work helps explain how cancer starts, why it can return, and how space-based research may speed the development of therapies that stop malignant stem cells before disease advances. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 41473]

People in this episode

Guests: Catriona Jamieson, M.D., Ph.D., Catriona Jamieson

Topics covered

• stem cell aging
• precancer evolution
• myeloproliferative neoplasms
• acute myeloid leukemia
• spaceflight research
• drug responses
• cancer therapies

Keywords

• stem cells
• cancer
• inflammation
• myeloproliferative neoplasms
• acute myeloid leukemia
• spaceflight
• ADAR1
• tumor organoids
• therapies

Mentioned in this episode

Organizations: UC San Diego, Stem Cell Channel

Books & works: Cancer Frontiers

More episodes of Cancer Frontiers (Audio)

• Prostate Cancer: Radiation Therapy for Local Recurrence · June 7, 2026 · 11 min
• Prostate Cancer: PSMA PET and Functional Imaging · June 4, 2026 · 16 min
• Targeted Therapies for Prostate Cancer · June 4, 2026 · 12 min
• Prostate Cancer Immunotherapy · June 3, 2026 · 11 min
• Prostate Cancer: Diet and Exercise · June 2, 2026 · 18 min
• Metastatic Hormone Sensitive Prostate Cancer: Understanding Your Diagnosis and Your Options · June 2, 2026 · 12 min